Improving The Quality Of Patient Care

ASPIRE, the Asia Pacific Initiative on Reproduction, is a unique task force of clinicians and scientists involved in the management of fertility and Assisted Reproductive Technology (ART). ASPIRE aims to promote awareness of infertility and ART, and to improve infertility-related services in the Asia-Pacific region.

More Information

The 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) will be held at the Philippine International Convention Center (PICC), Manila, Philippines from 23 – 26 May 2024. This annual congress is jointly organized by the Asia Pacific Initiative on Reproduction (ASPIRE) and the Philippine Society for Reproductive Medicine (PSRM).

The aim of ASPIRE 2024 is reflected by the congress theme: “Pearls of Wisdom in Reproductive Medicine: Towards Personalisation and Improving Access.” The scientific program promises to be exciting, with important topics presented by the most celebrated experts. It will also be ever more inclusive, with direct input from our two newly formed SIGs in Nursing and Counselling.

We look forward to welcoming you at ASPIRE 2024 in Manila! Mabuhay!

Read more

Message from President

Message from President

Our special interest groups (SIGs) continue to grow and flourish and I thank all the leaders who have committed to their new term of office and duties.  I welcome particularly our leaders and members of our two recently formed SIGs for nurses and counsellors.  The Board has approved the establishment of a SIG in Fertility Preservation to be led by Prof Rong Li.

I thank too, our country representatives who have committed to grow our membership and represent ASPIRE in the countries of the Asia Pacific region.  The country representatives will have a vital role in the future of ASPIRE, including the recently ASPIRE-endorsed programme Fertility Counts which we hope will pave the way to the restitution of reduced birth rates in many of the developed Asian countries.  I commend Fertility Counts to you, supported by Merck and developed in collaboration with The Economist Update, as a well-researched evidence-based toolkit for implementation across our region.

Read more